It was exactly this week, in 2020, when COVID officially entered the mass consciousness: The NBA suddenly canceled its season ...

Women and girls’ lives are being lost due to the abrupt and sweeping cancellation of U.S. assistance approved by Congress.

Bristol-Myers Squibb is on course to move its BCMA-targeting CAR-T therapy further up the treatment pathway in multiple myeloma, after reporting that it met its objectives in a phase 3 trial.

GT005 is a one-shot therapy which aims to treat GA by delivering the gene for complement factor I (CFI) to the eye using an adeno-associated virus (AAV) vector. CFI regulates the activity of the ...

Johnson & Johnson and Merck are laying off employees in China ... facility in Plainville provides viral vector services ranging from process development to commercial manufacturing. Charles River ...

That said, one stock that continues to stand out is Johnson & Johnson JNJ. The pharmaceutical giant's stock hit new 52-week highs of nearly $170 on Tuesday, with JNJ now up +16% year to date.

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor model based on the published strategy ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks. Stock market investors have enjoyed strong annual returns over the past two ...